NPI registry status
Active
2026 NPPES data Family Medicine Physician NPI 1528383668 MD
Verify on CMS → Tatsuzo Miakashi, MD
Family Medicine Physician in Roseville, California.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 150,125 in Family Medicine Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
4K
Medicare Part D claims · 480 beneficiaries · Family Medicine Physician avg: 4K
Generic prescribing
86%
generic claims · 12% brand-name · higher generic rates reduce patient out-of-pocket costs
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Tatsuzo Miakashi, MD filed 3,873 Medicare Part D claims in 2024 as a Family Medicine Physician in Roseville, California, prescribing 86% generic.
- 4K
- Part D claims, 2024
- 86%
- generic prescribing
- Likely
- board-certified (heuristic)
- ≥91st
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Tatsuzo Miakashi, MD
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1528383668), first enumerated 03/31/2010.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 3,873 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- State context
State board disciplinary context
California statewide board action statistics are published annually — these figures describe aggregate state activity, not Tatsuzo Miakashi, MD's individual license status. Verify directly with the state medical board.
Source: MBC annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1528383668 · Family Medicine Physician
NPI-10 · ENUM-MID · TAX-MEGA · RX-MID · BOOK-MID · PHOTO-ENUM
- NPI-10 1528383668
- ENUM-MID 2010
- TAX-MEGA 150K Family Medicine
- RX-MID 3,873
- BOOK-MID 16,272 in California
- PHOTO-ENUM Quratulain Bawaney · 2010
Tatsuzo Miakashi, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
3,873 ≥ 91st percentile 91% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
✓
Board certification likely (heuristic, not verified)
Tatsuzo Miakashi, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Tatsuzo Miakashi, MD?
Quality data not reportedPrimary specialty
Family Medicine Physician
Medicare Part D claims
3,873 10% vs specialty avg
Specialty distribution in California
How Family Medicine Physician compares to other specialties among California providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Family Medicine Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1528383668 |
|---|---|
| Specialty | Family Medicine Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 03/31/2010 |
Hospital and facility affiliations
Facilities where Tatsuzo Miakashi, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Sutter Valley Medical Foundation
Sacramento, CA
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
License & disciplinary context - California MBC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 - they are NOT specific to Tatsuzo Miakashi, MD. To verify Tatsuzo Miakashi, MD's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases
MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
Tatsuzo Miakashi, MD - brand share 12.0%
Family Medicine Physician average
12% brand-name claims vs 86% generic, on 3,873 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
3,873
Total Claims
$412K
Total Drug Cost
480
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 9,774.933
- Total Day Supply
- 287,609
- Brand vs Generic
- 12% brand / 86% generic
- Brand Drug Cost
- $348K
- Generic Drug Cost
- $61K
- Opioid Claims
- 121 (3.1% rate)
- Antibiotic Claims
- 21
Patient Demographics
- Average Patient Age
- 74.4 years
- Avg HCC Risk Score
- 1.09
- Gender Split
- 57% female / 43% male
- Age Distribution
- <65: 34, 65-74: 232, 75-84: 140, 85+: 74
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Tatsuzo Miakashi, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Atorvastatin Calcium
Atorvastatin Calcium
239 claims
- Levothyroxine Sodium
Levothyroxine Sodium
221 claims
- Amlodipine Besylate
Amlodipine Besylate
193 claims
- Lisinopril
Lisinopril
172 claims
- Losartan Potassium
Losartan Potassium
124 claims
- Rosuvastatin Calcium
Rosuvastatin Calcium
102 claims
- Metoprolol Succinate 93
Metoprolol Succinate
93 claims
- Gabapentin 86
Gabapentin
86 claims
| Drug | Claims |
|---|---|
| Atorvastatin Calcium | 239 |
| Levothyroxine Sodium | 221 |
| Amlodipine Besylate | 193 |
| Lisinopril | 172 |
| Losartan Potassium | 124 |
| Rosuvastatin Calcium | 102 |
| Metoprolol Succinate | 93 |
| Gabapentin | 86 |
| Simvastatin | 80 |
| Hydrochlorothiazide | 68 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Family Medicine Physician Overview
How Tatsuzo Miakashi, MD fits within the Family Medicine Physician landscape nationally.
150,125
Family Medicine Physician Providers in US
56
States with Family Medicine Physician
3,519
Avg Claims per Provider
Tatsuzo Miakashi, MD's 3,873 claims are above the specialty average of 3,519.
Nationwide Family Medicine Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Miakashi, both outside California so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2010)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Family Medicine Physician Providers in California
Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as Miakashi.
One of 16,272 Family Medicine Physician providers enrolled in California, 5 are shown here.
Dr. Omer Aba-Omer
MD
Santa Monica, CA
Dr. Michelle Ababa
MD
Wilmington, CA
Dr. Anna Tzeitel Abalos
MD
Roseville, CA
Dr. Adan Abarca
MD
Anaheim, CA
Dr. Vanessa Abarca
DO
Ventura, CA
Compare Family Medicine Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Tatsuzo Miakashi, MD's specialty? ▼
Tatsuzo Miakashi, MD specializes in Family Medicine Physician and practices in Roseville, California. Credentials: MD.
How much does Tatsuzo Miakashi, MD prescribe under Medicare Part D? ▼
In 2024, Tatsuzo Miakashi, MD wrote 3,873 Medicare Part D claims totaling $412K in drug costs for 480 beneficiaries.
Where is Tatsuzo Miakashi, MD located? ▼
Tatsuzo Miakashi, MD is located at 2050 BLUE OAKS BLVD, Roseville, CA, 95747. Phone: (916) 910-2500.
What is Tatsuzo Miakashi, MD's NPI number? ▼
Tatsuzo Miakashi, MD's National Provider Identifier (NPI) is 1528383668, issued on 03/31/2010.
Does Tatsuzo Miakashi, MD prescribe more brand-name or generic drugs? ▼
Tatsuzo Miakashi, MD's prescribing is 12% brand-name and 86% generic drugs by claim count, with $348K in brand drug costs.
Does Tatsuzo Miakashi, MD prescribe opioids? ▼
Yes, Tatsuzo Miakashi, MD had 121 opioid claims in 2024 with an opioid prescribing rate of 3.1%.
How many Family Medicine Physician providers are there in the US? ▼
There are 150,125 Family Medicine Physician providers across 56 states in the US. The average Family Medicine Physician provider writes 3,519 Medicare Part D claims per year.
What drugs does Tatsuzo Miakashi, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, Tatsuzo Miakashi, MD's most frequently prescribed drugs include Atorvastatin Calcium, Levothyroxine Sodium, Amlodipine Besylate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Tatsuzo Miakashi, MD accept Medicare? ▼
Tatsuzo Miakashi, MD appears in CMS Medicare data with 3,873 Part D claims and 480 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Tatsuzo Miakashi, MD's credentials? ▼
Tatsuzo Miakashi, MD's NPI is 1528383668 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.